Erectile dysfunction decisions — 2025

The Veteran's service connection for diabetes mellitus, type II was granted due to exposure to herbicides during his service in Panama. Other claims were remanded.

The Board denied service connection for sleep apnea and remanded the claims for erectile dysfunction and a skin rash on the legs, face, and back due to insufficient evidence.

The appeal for service connection for a left shoulder condition and sleep disorder condition was dismissed due to procedural defects, while other issues were remanded for further review.

The Board denied service connection for various disabilities, including right hip, left knee, right knee, diabetes mellitus, erectile dysfunction, and asthma. The initial rating for asthma was also denied.

The Board denied the veteran's claims for an increased evaluation for bilateral plantar fasciitis with left heel spur and a compensable evaluation for erectile dysfunction.

The Board denied a compensable disability rating for left lower extremity peripheral artery disease and erectile dysfunction, and remanded the claims for right lower extremity PAD and eligibility for assistance in acquiring specially adapted housing.

The Board granted service connection for coronary artery disease, denied an initial rating in excess of 20 percent for diabetes mellitus type II, and dismissed the claim for service connection for erectile dysfunction, with or without penile deformity.

The Board granted service connection for erectile dysfunction (ED) secondary to the Veteran's service-connected Parkinson's disease and remanded claims for higher ratings and an earlier effective date.

The Veteran's service connection for right knee strain was granted, while his claim for bilateral hearing loss and increased rating of PTSD prior to June 19, 2023, were also granted. Other claims were either denied or remanded.

The Board remands the matter for a new VA medical opinion to address whether the Veteran's erectile dysfunction is related to his service or secondary to his service-connected hypertension.

The Board remands the claims for further development and to correct a pre-decisional error of the duty to assist.

The Board granted an increased initial rating of 40 percent for voiding dysfunction status post urinary tract cancer and denied an increased initial rating in excess of 30 percent for a left nephrectomy due to urinary tract cancer. The remaining service connection claims were remanded.

The Board denied earlier effective dates for the grant of service connection for tinnitus, erectile dysfunction, and diabetic neuropathy affecting both upper extremities.

The Board denied the veteran's claims for increased ratings for right and left leg cramps, hemorrhoids, and erectile disorder, as the evidence did not support a higher rating than the currently assigned noncompensable or 10 percent ratings.

The Board granted service connection for COPD, a back disability, and erectile dysfunction, to include as secondary to the service-connected PTSD. The Veteran's PTSD was rated at 70 percent, and TDIU was also granted.

The appeal for service connection for tinnitus is dismissed as moot. The claims for service connection for asthma, hypertension, erectile dysfunction, and headaches were denied. An earlier effective date for the grant of service connection for hypertension was also denied.

The Board denied service connection for erectile dysfunction, left and right hand conditions, upper or lower back condition, neck condition, left and right ankle disabilities, and left and right knee disabilities as there was no evidence of a current disability related to active service.

The Board denied a rating higher than 20 percent for diabetes mellitus with erectile dysfunction as the Veteran's condition did not meet the criteria for a higher rating.

The Board remands the claims for service connection as they require further development, including new medical opinions and additional evidence.

The Board granted service connection for erectile dysfunction and right ankle sprain, restored a 20 percent rating for degenerative disc disease and intervertebral disc disease of the lumbar spine effective May 7, 2021, and denied earlier effective dates and increased ratings for other conditions.